FCCC LOGO Faculty Publications
Pembrolizumab plus ipilimumab or pegylated interferon alfa-2b for patients with melanoma or renal cell carcinoma: take new drugs but keep the old?
Ann Transl Med. 2019 Jul;7(Suppl 3) :S95
PMID: 31576303    PMCID: PMC6685891    URL: https://www.ncbi.nlm.nih.gov/pubmed/31576303
Back to previous list
Abstract
Notes
Zibelman, Matthew Plimack, Elizabeth R Editorial Comment China Ann Transl Med. 2019 Jul;7(Suppl 3):S95. doi: 10.21037/atm.2019.04.57.